亚洲 · 股市与财经 · The Financial Express
US Pharma Tariff Relief: Which Indian pharma stocks benefit and which face trade risk?
US pharma tariff relief has different implications for Indian drugmakers, with generic, specialty, injectable and CDMO businesses facing distinct risks and opportunities.
在 The Financial Express 阅读全文 登录后可收藏MediaNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (www.financialexpress.com)
